Technology created to treat terminal cancer patients when other methods fail. The treatment will take about three years, and over 800 individuals have been cured thanks to this medication.
This technology produces cancer treatment drugs based on human immune system cells. (Photo: Technologynetworks).
According to reporters in Moscow, scientists at the Petrov National Medical Research Center of Oncology in St. Petersburg, Russia, have developed a unique technology to produce cancer treatment drugs based on human immune system cells.
This medication is hoped to be beneficial for terminal cancer patients. The technology is based on blood taken from patients, processed, and then transfused back into other patients.
The astonishing results show that the drug has been effective even in the most hopeless cancer cases – including sarcoma, malignant tumors, and neuroblastoma.
In 40% of cases, the immune system begins to recognize and destroy cancer cells.
Ms. Irina Baldueva, Head of the Cancer Immunology Department, stated that this technology was created to treat terminal cancer patients when other methods fail. The treatment will take about three years, and over 800 individuals have been cured thanks to this medication. Many of them have been confirmed as “on the brink of death.”
The process of formulating this cancer treatment drug began in St. Petersburg in 1998 and continues to this day.
Currently, the production facilities of the cancer immunology laboratory are being restructured. Once the restructuring is completed, the drug production will be licensed and registered.
According to the plan, this drug is expected to begin mass production in 2024.
